Cortical and Subcortical 5-HT2A Receptor Binding in Neuroleptic-Naive First-Episode Schizophrenic Patients
about
Epigenetic Mechanisms of Serotonin Signaling.Serotonergic hallucinogens as translational models relevant to schizophrenia.Reduced levels of serotonin 2A receptors underlie resistance of Egr3-deficient mice to locomotor suppression by clozapine.Neuroimaging studies in schizophrenia: an overview of research from Asia.Advances in CNS Imaging Agents: Focus on PET and SPECT Tracers in Experimental and Clinical Use.Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part II: Cognition, neuroimaging and genetics.5-HT radioligands for human brain imaging with PET and SPECTFrom the prodrome to chronic schizophrenia: the neurobiology underlying psychotic symptoms and cognitive impairmentsBiomarker investigations related to pathophysiological pathways in schizophrenia and psychosis.The use of PET imaging in studying cognition, genetics and pharmacotherapeutic interventions in schizophrenia.How have developments in molecular imaging techniques furthered schizophrenia research?Serotonin 2A receptor antagonists for treatment of schizophrenia.Serotonin and molecular neuroimaging in humans using PET.In vitro and initial in vivo evaluation of (68)Ga-labeled transferrin receptor (TfR) binding peptides as potential carriers for enhanced drug transport into TfR expressing cells.Increased prefrontal cortical D₁ receptors in drug naive patients with schizophrenia: a PET study with [¹¹C]NNC112.Different patterns of 5-HT receptor and transporter dysfunction in neuropsychiatric disorders--a comparative analysis of in vivo imaging findings.
P2860
Q27027985-B8A6A9C8-932B-4F40-9205-9231E4488DE0Q30427074-092C28FF-BB14-4D12-B28C-98A5EFB2D609Q30524246-6517EDA6-2A3D-42A7-9179-C080B16DFAA9Q30573043-F32AEFB7-9AA7-40D8-9AA9-48FD79041168Q30945416-E0D0D099-E5BF-4A58-A243-BECC8D0D990CQ31108616-4114E5B6-3408-4282-827A-4F9BC17183A2Q34192729-7E1DED8F-88A5-4377-A193-03779B109A70Q36872150-7B944468-9970-483D-A568-3FC19DC98DB3Q36955877-655A2479-803A-4F60-B67A-EC701680ECFAQ37820985-3776CADC-54A8-46F0-B35F-2DD867017913Q37829639-B6CC670F-77C1-4C69-8B1D-74CC111CBCFCQ37899193-40E1165C-9C8B-44D0-8B5B-C6C151C21571Q37938794-2D4CC633-E930-4F10-9F2B-DAF8B0488D2BQ39703349-A0009598-59A0-4311-BEB4-2F74AD7A5289Q39991406-6982281E-7F6D-4784-A77F-E9927AE0829BQ48074706-F1370246-DA1D-43F5-A253-363EDE46C28C
P2860
Cortical and Subcortical 5-HT2A Receptor Binding in Neuroleptic-Naive First-Episode Schizophrenic Patients
description
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2008
@ast
im Februar 2008 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: 20 February 2008)
@en
wetenschappelijk artikel (gepubliceerd op 2008/02/20)
@nl
наукова стаття, опублікована в лютому 2008
@uk
مقالة علمية (نشرت في 20-2-2008)
@ar
name
Cortical and Subcortical 5-HT2 ...... Episode Schizophrenic Patients
@ast
Cortical and Subcortical 5-HT2 ...... Episode Schizophrenic Patients
@en
type
label
Cortical and Subcortical 5-HT2 ...... Episode Schizophrenic Patients
@ast
Cortical and Subcortical 5-HT2 ...... Episode Schizophrenic Patients
@en
prefLabel
Cortical and Subcortical 5-HT2 ...... Episode Schizophrenic Patients
@ast
Cortical and Subcortical 5-HT2 ...... Episode Schizophrenic Patients
@en
P2860
P50
P356
P1476
Cortical and Subcortical 5-HT2 ...... Episode Schizophrenic Patients
@en
P2093
Hans Rasmussen
Klaus T Kristiansen
P2860
P2888
P304
P356
10.1038/SJ.NPP.1301656
P407
P50
P577
2008-02-20T00:00:00Z
P5875
P6179
1043893140